Barnebey, H <br/><br/>
Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting.  [electronic resource] 

 -  Clinical therapeutics  Oct 2000 
 - 1204-12 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0149-2918 
<br/><br/><label>Standard No.: </label>10.1016/s0149-2918(00)83063-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carbonic Anhydrase Inhibitors--adverse effects<br/>Glaucoma--drug therapy<br/>Humans<br/>Intraocular Pressure--drug effects<br/>Patient Satisfaction<br/>Prospective Studies<br/>Sulfonamides--adverse effects<br/>Thiazines--adverse effects<br/>Thiophenes--adverse effects